Barclays’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $111M | Buy |
565,470
+232,168
| +70% | +$45.1M | 0.03% | 460 |
|
|
2025
Q4 | $57.8M | Buy |
333,302
+82,170
| +33% | +$15M | 0.01% | 713 |
|
|
2025
Q3 | $47.9M | Sell |
251,132
-105,269
| -30% | -$18.7M | 0.01% | 793 |
|
|
2025
Q2 | $64M | Sell |
356,401
-31,098
| -8% | -$5.4M | 0.01% | 616 |
|
|
2025
Q1 | $65.6M | Buy |
387,499
+123,145
| +47% | +$20.2M | 0.02% | 561 |
|
|
2024
Q4 | $39.9M | Sell |
264,354
-34,568
| -12% | -$5.38M | 0.01% | 767 |
|
|
2024
Q3 | $46.4M | Buy |
298,922
+78,980
| +36% | +$11.8M | 0.01% | 699 |
|
|
2024
Q2 | $30.1M | Sell |
219,942
-251,453
| -53% | -$34.4M | 0.01% | 798 |
|
|
2024
Q1 | $62.7M | Buy |
471,395
+90,244
| +24% | +$11.7M | 0.02% | 523 |
|
|
2023
Q4 | $52.6M | Buy |
381,151
+135,687
| +55% | +$17.8M | 0.02% | 639 |
|
|
2023
Q3 | $29.9M | Sell |
245,464
-58,210
| -19% | -$7.76M | 0.02% | 648 |
|
|
2023
Q2 | $42.7M | Buy |
303,674
+84,859
| +39% | +$11.7M | 0.03% | 495 |
|
|
2023
Q1 | $31M | Sell |
218,815
-122,647
| -36% | -$17.5M | 0.01% | 671 |
|
|
2022
Q4 | $53.4M | Buy |
341,462
+15,885
| +5% | +$2.28M | 0.02% | 465 |
|
|
2022
Q3 | $39.9M | Buy |
325,577
+30,838
| +10% | +$4.06M | 0.04% | 375 |
|
|
2022
Q2 | $39.2M | Sell |
294,739
-5,278
| -2% | -$719K | 0.02% | 469 |
|
|
2022
Q1 | $41.1M | Sell |
300,017
-13,281
| -4% | -$1.85M | 0.03% | 470 |
|
|
2021
Q4 | $54.2M | Sell |
313,298
-79,707
| -20% | -$12.1M | 0.02% | 548 |
|
|
2021
Q3 | $57.1M | Buy |
393,005
+52,106
| +15% | +$7.62M | 0.03% | 468 |
|
|
2021
Q2 | $45M | Buy |
340,899
+75,011
| +28% | +$9.82M | 0.02% | 565 |
|
|
2021
Q1 | $34.1M | Buy |
265,888
+18,587
| +8% | +$2.29M | 0.02% | 593 |
|
|
2020
Q4 | $29.5M | Buy |
247,301
+76,823
| +45% | +$9.37M | 0.02% | 658 |
|
|
2020
Q3 | $19.5M | Buy |
170,478
+80,993
| +91% | +$9.57M | 0.01% | 759 |
|
|
2020
Q2 | $10.2M | Sell |
89,485
-27,374
| -23% | -$2.9M | 0.01% | 947 |
|
|
2020
Q1 | $9.38M | Sell |
116,859
-179,815
| -61% | -$18.6M | 0.01% | 1023 |
|
|
2019
Q4 | $31.7M | Buy |
296,674
+92,125
| +45% | +$9.61M | 0.02% | 712 |
|
|
2019
Q3 | $21.9M | Sell |
204,549
-23,366
| -10% | -$2.4M | 0.01% | 828 |
|
|
2019
Q2 | $23.2M | Buy |
227,915
+32,046
| +16% | +$3.08M | 0.01% | 837 |
|
|
2019
Q1 | $17.6M | Buy |
195,869
+45,836
| +31% | +$3.97M | 0.01% | 921 |
|
|
2018
Q4 | $12.5M | Sell |
150,033
-194,380
| -56% | -$18.2M | 0.01% | 1024 |
|
|
2018
Q3 | $37.2M | Buy |
344,413
+142,016
| +70% | +$15.6M | 0.03% | 541 |
|
|
2018
Q2 | $22.3M | Sell |
202,397
-71,451
| -26% | -$7.44M | 0.02% | 740 |
|
|
2018
Q1 | $27.5M | Buy |
273,848
+37,455
| +16% | +$3.84M | 0.02% | 692 |
|
|
2017
Q4 | $23.3M | Buy |
236,393
+67,036
| +40% | +$6.36M | 0.02% | 727 |
|
|
2017
Q3 | $15.9M | Buy |
169,357
+59,834
| +55% | +$6.35M | 0.02% | 769 |
|
|
2017
Q2 | $12.2M | Sell |
109,523
-35,970
| -25% | -$3.8M | 0.01% | 855 |
|
|
2017
Q1 | $14.3M | Buy |
145,493
+66,052
| +83% | +$6.3M | 0.02% | 692 |
|
|
2016
Q4 | $7.3M | Sell |
79,441
-17,399
| -18% | -$1.5M | 0.01% | 1132 |
|
|
2016
Q3 | $8.19M | Buy |
96,840
+4,584
| +5% | +$385K | 0.01% | 983 |
|
|
2016
Q2 | $7.51M | Buy |
92,256
+13,630
| +17% | +$1.04M | 0.01% | 1019 |
|
|
2016
Q1 | $5.58M | Buy |
78,626
+31,742
| +68% | +$2.13M | 0.01% | 1100 |
|
|
2015
Q4 | $3.33M | Sell |
46,884
-13,416
| -22% | -$902K | ﹤0.01% | 1614 |
|
|
2015
Q3 | $3.68M | Sell |
60,300
-19,755
| -25% | -$1.38M | ﹤0.01% | 1580 |
|
|
2015
Q2 | $5.76M | Sell |
80,055
-21,278
| -21% | -$1.57M | 0.01% | 1387 |
|
|
2015
Q1 | $7.7M | Sell |
101,333
-490
| -0.5% | -$35.1K | 0.01% | 1242 |
|
|
2014
Q4 | $6.82M | Buy |
101,823
+19,291
| +23% | +$1.22M | 0.01% | 1452 |
|
|
2014
Q3 | $4.95M | Buy |
82,532
+12,252
| +17% | +$755K | ﹤0.01% | 1784 |
|
|
2014
Q2 | $4.08M | Sell |
70,280
-73,892
| -51% | -$4.33M | ﹤0.01% | 1939 |
|
|
2014
Q1 | $8.22M | Sell |
144,172
-111,821
| -44% | -$5.99M | 0.01% | 1299 |
|
|
2013
Q4 | $13.6M | Sell |
255,993
-16,585
| -6% | -$984K | 0.01% | 1033 |
|
|
2013
Q3 | $16.6M | Buy |
272,578
+128,710
| +89% | +$7.7M | 0.02% | 791 |
|
|
2013
Q2 | $8.72M | Buy |
+143,868
| New | +$8.57M | 0.01% | 1179 |
|
Other funds holding DGX
VCM
VPM
EIG
Barclays's DGX Position: Q1 2026 in Review
Barclays increased its Quest Diagnostics (DGX) stake by 70% in Q1 2026, buying an estimated $45.1M and bringing the position to 565,470 shares worth $111M. The position accounts for 0.03% of the portfolio, ranked #460.
Barclays first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Barclays held 565,470 shares of Quest Diagnostics worth $111M as of Q1 2026.
- Barclays bought 232,168 Quest Diagnostics shares in Q1 2026, an estimated $45.1M.
- Quest Diagnostics made up 0.03% of Barclays's portfolio in Q1 2026, its #460 holding.
- Barclays first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
- 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.